At this time, the tumor growth rate in the hepatocellular carcinoma xenograft model was significantly reduced, confirming that it is an effective method to prevent the formation of the YAP-TEAD complex by directly targeting TEAD 103. This evidence concerns the gene YAP1 and hepatocellular carcinoma.